Daniel Abramowicz

19.3k total citations · 4 hit papers
280 papers, 13.3k citations indexed

About

Daniel Abramowicz is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Daniel Abramowicz has authored 280 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Transplantation, 72 papers in Surgery and 64 papers in Immunology. Recurrent topics in Daniel Abramowicz's work include Renal Transplantation Outcomes and Treatments (115 papers), Organ Transplantation Techniques and Outcomes (48 papers) and Organ Donation and Transplantation (42 papers). Daniel Abramowicz is often cited by papers focused on Renal Transplantation Outcomes and Treatments (115 papers), Organ Transplantation Techniques and Outcomes (48 papers) and Organ Donation and Transplantation (42 papers). Daniel Abramowicz collaborates with scholars based in Belgium, France and Netherlands. Daniel Abramowicz's co-authors include Michel Goldman, Karl Martin Wissing, P Vereerstraeten, Thierry Velu, Catherine Gérard, Nilüfer Broeders, Peter Vandenabeele, Alaín Le Moine, Catherine Bruyns and Christian Tielemans and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Daniel Abramowicz

274 papers receiving 12.8k citations

Hit Papers

Rapidly progressive interstitial renal fibrosis in young ... 1993 2026 2004 2015 1993 2000 2007 1993 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Abramowicz Belgium 60 4.0k 3.0k 2.9k 2.0k 1.8k 280 13.3k
Claudio Ponticelli Italy 65 2.9k 0.7× 2.1k 0.7× 2.0k 0.7× 1.6k 0.8× 2.8k 1.6× 464 16.4k
Ulrich Frei Germany 50 2.9k 0.7× 2.9k 1.0× 792 0.3× 1.7k 0.8× 1.4k 0.8× 242 11.4k
Norberto Perico Italy 65 3.2k 0.8× 3.7k 1.2× 1.7k 0.6× 853 0.4× 1.5k 0.9× 292 14.2k
Francesco Paolo Schena Italy 64 2.3k 0.6× 2.2k 0.8× 2.3k 0.8× 1.2k 0.6× 1.5k 0.9× 279 14.1k
Borja G. Cosío Spain 57 3.6k 0.9× 2.4k 0.8× 1.6k 0.6× 1.0k 0.5× 5.5k 3.1× 266 12.4k
Walter H. Hörl Austria 61 1.6k 0.4× 2.4k 0.8× 2.2k 0.8× 1.4k 0.7× 1.5k 0.8× 393 13.4k
Chul Woo Yang South Korea 47 1.9k 0.5× 2.2k 0.8× 1.1k 0.4× 1.1k 0.6× 1.4k 0.8× 526 9.8k
Yves Vanrenterghem Belgium 62 5.5k 1.4× 3.2k 1.1× 832 0.3× 1.4k 0.7× 1.3k 0.8× 267 12.7k
Manuel Praga Spain 51 836 0.2× 1.5k 0.5× 1.1k 0.4× 839 0.4× 1.9k 1.1× 330 10.7k
Jan Schmidt Germany 52 931 0.2× 3.6k 1.2× 1.3k 0.5× 1.4k 0.7× 1.4k 0.8× 242 8.4k

Countries citing papers authored by Daniel Abramowicz

Since Specialization
Citations

This map shows the geographic impact of Daniel Abramowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Abramowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Abramowicz more than expected).

Fields of papers citing papers by Daniel Abramowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Abramowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Abramowicz. The network helps show where Daniel Abramowicz may publish in the future.

Co-authorship network of co-authors of Daniel Abramowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Abramowicz. A scholar is included among the top collaborators of Daniel Abramowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Abramowicz. Daniel Abramowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouziotis, Jason, Kevin K. Ariën, Joachim Mariën, et al.. (2024). Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. Virology Journal. 21(1). 138–138. 1 indexed citations
2.
Hilbrands, Luuk B., Gabriel C. Oniscu, Ilaria Gandolfini, et al.. (2024). Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group. Clinical Kidney Journal. 18(1). sfae367–sfae367.
3.
Hellemans, Rachel, et al.. (2023). Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis. Transplantation Proceedings. 55(1). 123–128. 1 indexed citations
4.
Abrams, Steven, Rachel Hellemans, Annick Massart, et al.. (2022). Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis. Nephrology Dialysis Transplantation. 37(8). 1566–1575. 11 indexed citations
5.
Vart, Priya, Raphaël Duivenvoorden, Casper Franssen, et al.. (2022). Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration. Nephrology Dialysis Transplantation. 38(3). 575–582. 2 indexed citations
6.
Roosens, Laurence, et al.. (2022). Pseudo-acute kidney injury secondary to tepotinib. Clinical Kidney Journal. 16(4). 760–761. 10 indexed citations
7.
Ariën, Kevin K., Steven Abrams, Marie M. Couttenye, et al.. (2021). mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?. Nephrology Dialysis Transplantation. 37(4). 799–803. 12 indexed citations
8.
Oniscu, Gabriel C., Daniel Abramowicz, Davide Bolignano, et al.. (2021). Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA. Nephrology Dialysis Transplantation. 37(Supplement_1). i1–i15. 38 indexed citations
9.
Gielis, Els M., Charlie Beirnaert, Amélie Dendooven, et al.. (2018). Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay. PLoS ONE. 13(12). e0208207–e0208207. 58 indexed citations
10.
Montero, Núria, María José Pérez‐Sáez, Julio Pascual, et al.. (2016). Immunosuppression in the elderly renal allograft recipient: a systematic review. Transplantation Reviews. 30(3). 144–153. 21 indexed citations
11.
Gielis, Els M., Kristien J. Ledeganck, Hans Wils, et al.. (2016). SO002QUANTIFICATION OF PLASMA DONOR-DERIVED CELL-FREE DNA TO MONITOR KIDNEY TRANSPLANT HEALTH: PRELIMINARY RESULTS OF A SINGLE TUBE MULTIPLEX PCR ASSAY. Nephrology Dialysis Transplantation. 31(suppl_1). i1–i1. 4 indexed citations
12.
Abramowicz, Daniel, Tomé Najdovski, P Kinnaert, et al.. (2015). Urinary Endopeptidase 24.11 as a New Marker of Proximal Tubular Injury. Contributions to nephrology. 101. 169–176. 1 indexed citations
13.
Spasovski, Goce, Pierre Cochat, Uwe Heemann, et al.. (2014). European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care. 68(1). 1–7. 6 indexed citations
14.
Humar, Abhi, Y Lebranchu, Flavio Vincenti, et al.. (2009). The IMPACT Study: Valganciclovir Prophylaxis for until 200 Days Post-Transplant in High Risk Kidney Recipients Substantially Reduces the Incidence of CMV Disease.. Ghent University Academic Bibliography (Ghent University). 10 indexed citations
15.
Jayne, David, Gill Gaskin, Niels Rasmussen, et al.. (2007). Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis. Journal of the American Society of Nephrology. 18(7). 2180–2188. 706 indexed citations breakdown →
16.
Knoop, Christiane, et al.. (2000). IMPAIRED ANTIGEN-PRESENTING CELL FUNCTION CONTRIBUTES TO T-CELL HYPORESPONSIVENESS IN STABLE LUNG TRANSPLANT RECIPIENTS1. Transplantation. 69(7). 1332–1336. 2 indexed citations
17.
Kreis, Henri, Jean‐Marc Cisterne, W. Land, et al.. (2000). SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12. Transplantation. 69(7). 1252–1260. 456 indexed citations
18.
Blanpain, Cédric, Christiane Knoop, Marie‐Luce Delforge, et al.. (1998). REACTIVATION OF HEPATITIS B AFTER TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING ANTI-HEPATITIS B SURFACE ANTIGEN ANTIBODIES. Transplantation. 66(7). 883–886. 89 indexed citations
19.
Abramowicz, Daniel, et al.. (1995). Accelerated biodegradation of PCBs. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 25(7). 36–41. 13 indexed citations
20.
Abramowicz, Daniel, Michel Goldman, Catherine Bruyns, Y Thoua, & Jacques Urbain. (1985). Persistant Chimerism, Anti-arsonate Response and Immunopathology After Neonatal Induction of Transplantation Tolerance. Kidney International. 28(2). 268–268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026